iFDA: Social Media, the Internet, and Drug Regulation
This article was originally published in RPM Report
Promotion and marketing is no longer limited to television, newspapers, magazines and journals. The internet is taking on a bigger role in getting through to consumers and doctors. FDA is focusing on how to regulate the rapidly changing landscape. For drug manufacturers, adding clarity is a good thing.
You may also be interested in...
Congress agrees with the pharmaceutical industry that the right to advertise new drugs is protected by the First Amendment. But pharma companies have a long way to go to prove to their critics that it is the right thing to do.
Former FDA Associate Commissioner for External Relations Peter Pitts explains the emergence of blogging in the health care world and the value the practice serves for discussing health policy.
With landmark advisory committee meetings coming up, we take a look back at some of the memorable panel meetings over the last 20 years. This is Part II in the series.